UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Off-site healthcare scientist led carpal tunnel screening clinic useful or not?

Clinical neurophysiology, 2007-05, Vol.118 (5), p.e144-e144

2007

Volltextzugriff (PDF)

Effect of β-glucanase and β-xylanase enzyme supplemented barley diets on nutrient digestibility, growth performance and expression of intestinal nutrient transporter genes in finisher pigs

Animal feed science and technology, 2018-04, Vol.238, p.98-110

2018

Volltextzugriff (PDF)

Growth performance, nutrient digestibility and carcass characteristics of finisher pigs offered either a by-product or cereal based diet at two different concentrations of net energy

Animal feed science and technology, 2018-08, Vol.242, p.77-85

2018

Volltextzugriff (PDF)

Mycotoxin binder increases growth performance, nutrient digestibility and digestive health of finisher pigs offered wheat based diets grown under different agronomical conditions

Animal feed science and technology, 2018-06, Vol.240, p.52-65

2018

Volltextzugriff (PDF)

I DO LIKE THE WAY I LOOK: OLDER MEN’S PERCEPTIONS AND EXPERIENCES OF AGING AND BODY IMAGE

Innovation in aging, 2017-07, Vol.1 (suppl_1), p.1296-1297

2017

Volltextzugriff (PDF)

AGEING BODY AND SOCIETY: CRITICAL PERSPECTIVES, FUTURE CHALLENGES

Innovation in aging, 2017-07, Vol.1 (suppl_1), p.939-939

2017

Volltextzugriff (PDF)

History of the Bengal Nursing Council

Nursing Journal of India, 1940, Vol.XXXI (4), p.520-521

Clarke, L.C.

1940

Volltextzugriff (PDF)

1768MO Incidence of fracture related hospitalisations in men with de novo high risk localised and metastatic hormone sensitive prostate cancer: Analysis of routinely collected healthcare data from the STAMPEDE docetaxel and zoledronic acid comparisons

Annals of oncology, 2023-10, Vol.34, p.S956-S957

2023

Volltextzugriff (PDF)

LBA70 Adding metformin to androgen deprivation therapy (ADT) for patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC): Overall survival (OS) results from the multi-arm, multi-stage randomised platform trial STAMPEDE

Annals of oncology, 2024-09, Vol.35, p.S1258-S1259

2024

Volltextzugriff (PDF)

1656TiP The STAMPEDE2 niraparib-abiraterone acetate + prednisolone trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) with a deleterious alteration in a homologous recombination repair (HRR) gene starting androgen deprivation therapy (ADT)

Annals of oncology, 2024-09, Vol.35, p.S998-S999

2024

Volltextzugriff (PDF)

1596O Decipher mRNA score for prediction of survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for advanced prostate cancer (PC): An ancillary study of the STAMPEDE docetaxel trials

Annals of oncology, 2024-09, Vol.35, p.S961-S962

2024

Volltextzugriff (PDF)

PO-1534 STAMPEDE2 trial: A site survey of current patterns of care, access to imaging and treatment

Radiotherapy and oncology, 2023-05, Vol.182, p.S1245-S1246

2023

Volltextzugriff (PDF)

Fracture-related hospitalisations in de novo advanced or metastatic hormone-sensitive prostate cancer: Secondary analysis of the STAMPEDE abiraterone acetate plus prednisone +/- enzalutamide and M1|RT phase 3 trials using health systems data

European urology, 2024-03, Vol.85, p.S1583

2024

Volltextzugriff (PDF)

A0645 - Fracture-related hospitalisations in de novo advanced or metastatic hormone-sensitive prostate cancer: Secondary analysis of the STAMPEDE abiraterone acetate plus prednisone +/- enzalutamide and M1|RT phase 3 trials using health systems data

European urology, 2024-03, Vol.85, p.S1583-S1583

2024

Volltextzugriff (PDF)

Predictors of the need for surgery in upper gastrointestinal bleeding in a resource constrained setting: the Pietermaritzburg experience

South African Journal of Surgery, 2020-12, Vol.58 (4), p.199-203

2020

Volltextzugriff (PDF)

Mg in aragonitic bivalve shells: Seasonal variations and mode of incorporation in Arctica islandica

Chemical geology, 2008-08, Vol.254 (1), p.113-119

2008

Volltextzugriff (PDF)

Ion acceleration and plasma jet formation in ultra-thin foils undergoing expansion and relativistic transparency

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2016-09, Vol.829, p.163-166

2016

Volltextzugriff (PDF)

1657TiP The STAMPEDE2 stereotactic ablative body radiotherapy (SABR) trial: A phase III, randomised, open-label trial in patients with newly diagnosed oligometastatic prostate cancer (PC) starting androgen deprivation therapy (ADT)

Annals of oncology, 2024-09, Vol.35, p.S999-S999

2024

Volltextzugriff (PDF)

1658TiP The STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617) trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) starting androgen deprivation therapy (ADT)

Annals of oncology, 2024-09, Vol.35, p.S999-S1000

2024

Volltextzugriff (PDF)

1359MO Differential treatment response with nodal metastases in metastatic hormone-sensitive prostate cancer (mHSPC) and evaluation of nodal (N) burden as a prognostic biomarker: Ancillary studies of the docetaxel and abiraterone acetate and prednisolone (AAP) phase III trials from STAMPEDE

Annals of oncology, 2022-09, Vol.33, p.S1161-S1162

2022

Volltextzugriff (PDF)

The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access to Imaging and Treatment of Metastatic Prostate Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2023-10, Vol.35 (10), p.e628-e635

2023

Volltextzugriff (PDF)

Ten considerations for conservation policy makers for the post-COVID-19 transition

Environmental reviews, 2021-06, Vol.29 (2), p.111-118

2021

Volltextzugriff (PDF)

LBA4 Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men with high-risk non-metastatic (M0) prostate cancer (PCa): Combined analysis from two comparisons in the STAMPEDE platform protocol

Annals of oncology, 2021-09, Vol.32, p.S1298-S1298

2021

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Off-site healthcare scientist led carpal tunnel screening clinic useful or not?

Effect of β-glucanase and β-xylanase enzyme supplemented barley diets on nutrient digestibility, growth performance and expression of intestinal nutrient transporter genes in finisher pigs

Growth performance, nutrient digestibility and carcass characteristics of finisher pigs offered either a by-product or cereal based diet at two different concentrations of net energy

Mycotoxin binder increases growth performance, nutrient digestibility and digestive health of finisher pigs offered wheat based diets grown under different agronomical conditions

I DO LIKE THE WAY I LOOK: OLDER MEN’S PERCEPTIONS AND EXPERIENCES OF AGING AND BODY IMAGE

AGEING BODY AND SOCIETY: CRITICAL PERSPECTIVES, FUTURE CHALLENGES

History of the Bengal Nursing Council

Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis

1768MO Incidence of fracture related hospitalisations in men with de novo high risk localised and metastatic hormone sensitive prostate cancer: Analysis of routinely collected healthcare data from the STAMPEDE docetaxel and zoledronic acid comparisons

LBA70 Adding metformin to androgen deprivation therapy (ADT) for patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC): Overall survival (OS) results from the multi-arm, multi-stage randomised platform trial STAMPEDE

1656TiP The STAMPEDE2 niraparib-abiraterone acetate + prednisolone trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) with a deleterious alteration in a homologous recombination repair (HRR) gene starting androgen deprivation therapy (ADT)

1596O Decipher mRNA score for prediction of survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for advanced prostate cancer (PC): An ancillary study of the STAMPEDE docetaxel trials

PO-1534 STAMPEDE2 trial: A site survey of current patterns of care, access to imaging and treatment

Fracture-related hospitalisations in de novo advanced or metastatic hormone-sensitive prostate cancer: Secondary analysis of the STAMPEDE abiraterone acetate plus prednisone +/- enzalutamide and M1|RT phase 3 trials using health systems data

A0645 - Fracture-related hospitalisations in de novo advanced or metastatic hormone-sensitive prostate cancer: Secondary analysis of the STAMPEDE abiraterone acetate plus prednisone +/- enzalutamide and M1|RT phase 3 trials using health systems data

Predictors of the need for surgery in upper gastrointestinal bleeding in a resource constrained setting: the Pietermaritzburg experience

Mg in aragonitic bivalve shells: Seasonal variations and mode of incorporation in Arctica islandica

Ion acceleration and plasma jet formation in ultra-thin foils undergoing expansion and relativistic transparency

1657TiP The STAMPEDE2 stereotactic ablative body radiotherapy (SABR) trial: A phase III, randomised, open-label trial in patients with newly diagnosed oligometastatic prostate cancer (PC) starting androgen deprivation therapy (ADT)

1658TiP The STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617) trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) starting androgen deprivation therapy (ADT)

1359MO Differential treatment response with nodal metastases in metastatic hormone-sensitive prostate cancer (mHSPC) and evaluation of nodal (N) burden as a prognostic biomarker: Ancillary studies of the docetaxel and abiraterone acetate and prednisolone (AAP) phase III trials from STAMPEDE

The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access to Imaging and Treatment of Metastatic Prostate Cancer

1767MO External validation of a digital pathology-based multimodal artificial intelligence (MMAI)-derived model in high-risk localized (M0)/metastatic (M1) prostate cancer (PCa) starting androgen deprivation therapy (ADT) in the docetaxel (Doc) or abiraterone (AAP) phase III STAMPEDE trials

Ten considerations for conservation policy makers for the post-COVID-19 transition

LBA4 Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men with high-risk non-metastatic (M0) prostate cancer (PCa): Combined analysis from two comparisons in the STAMPEDE platform protocol

Aktive Filter

Suchergebnisse filtern